B. Bouma

C. Maas, T. Hackeng, B. Bouma, 2008, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Requirements of von Willebrand factor to protect factor VIII from inactivation by activated protein C.

J. Sixma, M. Schiphorst, T. Vink, 1996, Blood.

Involvement of amino acid residues 423-429 of human protein S in binding to C4b-binding protein.

P. Reitsma, J. Griffin, J. A. Fernandez, 1998, Blood cells, molecules & diseases.

Quality control material containing hemoglobin for blood gas and pH measurement: preparation of stroma-free hemoglobin solution.

W. Zijlstra, B. Bouma, A. Maas, 1987, Scandinavian journal of clinical and laboratory investigation. Supplementum.

Typing of fibrinogen degradation products in urine in various clinical disorders.

I. Nilsson, B. Bouma, U. Hedner, 1971, Scandinavian journal of clinical and laboratory investigation.

Lupus Anticoagulant Activity Is Frequently Dependent on the Presence of β2-Glycoprotein I

R. Derksen, B. Bouma, P. D. de Groot, 1992, Thrombosis and Haemostasis.

Fibrinolytic Activity in Blood Is Distributed over a Cellular and the Plasma Fraction which Can Be Modulated Separately

B. Bouma, J. V. van Giezen, J. Jansen, 1994, Thrombosis and Haemostasis.

Elimination of Intravenously Administered Radiolabelled Antithrombin III and Heparin in Humans

J. Sixma, B. Bouma, L. Andersson, 1984, Thrombosis and Haemostasis.

Studies on components of the contact phase system in patients with advanced gastrointestinal cancer

A. Aasen, A O Aasen, B N Bouma, 1990, Cancer.

The results of a comparison of the tanned red cell hemagglutination inhibition immuno-assay with an immunochemical method for the determination of splitproducts.

B. Bouma, 2009, Scandinavian journal of haematology. Supplementum.

C4b-binding Protein Inhibits the Factor V-dependent but not the Factor V-independent Cofactor Activity of Protein S in the Activated Protein C-mediated Inactivation of Factor VIIIa

J. Meijers, B. Bouma, R. H. van de Poel, 2001, Thrombosis and Haemostasis.

C4b-binding protein (C4BP) beta-chain Short Consensus Repeat-2 specifically contributes to the interaction of C4BP with protein S.

B. Dahlbäck, J. Meijers, B. Bouma, 1999, Blood cells, molecules & diseases.

Interaction between Protein S and Complement C4b-binding Protein (C4BP)

J. Meijers, B. Bouma, R. H. van de Poel, 1999, The Journal of Biological Chemistry.

Interaction of human plasma kallikrein and its light chain with alpha 2-macroglobulin.

B. Bouma, F. van der Graaf, A. Rietveld, 1984, Biochemistry.

Interaction of human plasma kallikrein and its light chain with C1 inhibitor.

J. Griffin, B. Bouma, F. van der Graaf, 1983, Biochemistry.

Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma

J. Griffin, C. Cochrane, B N Bouma, 1978, The Journal of experimental medicine.

Peritoneal lavage efficiently eliminates protease-alpha-2-macroglobulin complexes and components of the contact system from the peritoneal cavity in patients with severe acute pancreatitis.

A. Aasen, B. Bouma, T. Ruud, 1989, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

Studies of the Interaction between Human Protein S and Human C4b-Binding Protein Using Deletion Variants of Recombinant Human Protein S

P. Reitsma, R. Bertina, B. Bouma, 1994, Thrombosis and Haemostasis.

Identification of Different Forms of Human C4b-Binding Protein Lacking β-Chain and Protein S Binding Ability

T. Hackeng, B. Bouma, D. Kanters, 1990, Thrombosis and Haemostasis.

Evaluation of the detection rate of hemophilia carriers.

J. Hermans, B. Bouma, J. Veltkamp, 1975, Thrombosis research.

Prekallikrein activation and kallikrein inactivation in human plasma.

B. Bouma, F. van der Graaf, A. Rietveld, 1983, Advances in experimental medicine and biology.

Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation.

C. Maas, B. Hazenberg, P. D. de Groot, 2008, The Journal of clinical investigation.

Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis.

P. A. von dem Borne, J. Meijers, B N Bouma, 1995, Blood.

Oral contraceptives reduce total protein S, but not free protein S.

W. Erich, J. Meijers, B. Bouma, 1987, Thrombosis research.

Oral contraceptives and the risk of venous thrombosis.

J. Vandenbroucke, F. Rosendaal, S. Middeldorp, 2001, The New England journal of medicine.

Elucidating the structural chemistry of glycosaminoglycan recognition by protein C inhibitor.

J. Tainer, L. Kuhn, J. Griffin, 1990, Proceedings of the National Academy of Sciences of the United States of America.

The Role of Protein S in the Activation of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) and Regulation of Fibrinolysis

J. Meijers, B. Bouma, L. Mosnier, 2001, Thrombosis and Haemostasis.

The Effect of Oral Contraceptives and Exercise on Hemostatic and Fibrinolytic Mechanisms in Trained Women

W. Erich, B. Bouma, I. A. Huisveld, 1983, International journal of sports medicine.

Regulation of Fibrinolysis by Thrombin Activatable Fibrinolysis Inhibitor, an Unstable Carboxypeptidase B That Unites the Pathways of Coagulation and Fibrinolysis

B. Bouma, L. Mosnier, 2001, Arteriosclerosis, thrombosis, and vascular biology.

Effect of Lipoprotein(a) and LDL on Plasminogen Binding to Extracellular Matrix and on Matrix-dependent Plasminogen Activation by Tissue Plasminogen Activator

B. Bouma, H. V. van Rijn, H. Kleinveld, 1996, Thrombosis and Haemostasis.

In Vitro Studies of Antiphospholipid Antibodies and Its Cofactor, β2-Glycoprotein I, Show Negligible Effects on Endothelial Cell Mediated Protein C Activation

K. Preissner, R. Derksen, T. Hackeng, 1991, Thrombosis and Haemostasis.

Structure‐function studies on human C4b‐binding protein using monoclonal antibodies

J. Sixma, H. Heijnen, T. Hackeng, 1991, European journal of immunology.

The Identification and Significance of a Thr→Pro Polymorphism in Kringle IV Type 8 of Apolipoprotein(a)

J. Kastelein, B. Bouma, H. V. van Rijn, 1997, Thrombosis and Haemostasis.

von Willebrand factor as a regulator of intrinsic factor X activation.

J. Sixma, D. Stern, P. Nawroth, 1994, The Journal of laboratory and clinical medicine.

Oral contraceptives and fibrinolysis among female cyclists before and after exercise.

A. Hospers, W. Erich, B. Bouma, 1982, Journal of applied physiology: respiratory, environmental and exercise physiology.

Characterization and ATPase activity of human platelet actomyosin.

J. Sixma, J. Lindemans, B. Bouma, 1974, Thrombosis research.

Development of a Genotype 325–Specific proCPU/TAFI ELISA

Els Brouwers, Ann Gils, A. Gils, 2003, Arteriosclerosis, thrombosis, and vascular biology.

randomized trial C system in the absence or presence of the factor VLeiden mutation: a Effect of second- and third-generation oral contraceptives on the protein

A. Algra, D. Grobbee, J. Rosing, 2013 .

Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?

B. Bouma, L. Mosnier, 2006, Annals of medicine.

Effect of endurance training and seasonal fluctuation on coagulation and fibrinolysis in young sedentary men.

W. Mosterd, B. Bouma, I. A. Huisveld, 1997, Journal of applied physiology.

Construction and Characterization of Thrombin-resistant Variants of Recombinant Human Protein S

P. Reitsma, R. Bertina, T. Hackeng, 1994, Thrombosis and Haemostasis.

The interaction between anticoagulant protein S and complement regulatory C4b-binding protein (C4BP).

J. Meijers, B. Bouma, R. H. van de Poel, 2000, Trends in cardiovascular medicine.

Plasma protein S contains zinc essential for efficient activated protein C‐independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue factor pathway inhibitor

J. Griffin, B. Bouma, M. Heeb, 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

A Plasma Coagulation Assay for an Activated Protein C-independent Anticoagulant Activity of Protein S

R. Bertina, C. van ′t Veer, J. Meijers, 1998, Thrombosis and Haemostasis.

human platelets Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in

J. Meijers, B. Bouma, P. Buijtenhuijs, 2013 .

Increased plasmin‐α2‐antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses

C. Maas, B. Hazenberg, H. Lokhorst, 2007, Journal of thrombosis and haemostasis : JTH.

Factor XI Activation by Meizothrombin: Stimulation by Phospholipid Vesicles Containing both Phosphatidylserine and Phosphatidylethanolamine

J. Meijers, B. Bouma, G. Tans, 1997, Thrombosis and Haemostasis.

Heterogeneity of human factor VIII. III. Transitions between forms of factor VIII present in cryoprecipitate and in cryosupernatant plasma.

J. Sixma, B. Bouma, P. Bolhuis, 1980, The Journal of laboratory and clinical medicine.

Survival of iodine-125-labeled factor VIII in patients with von Willebrand's disease.

J. Sixma, B. Bouma, P. Bolhuis, 1981, The Journal of laboratory and clinical medicine.

THE DOSE DEPENDENCE OF ENDOTOXIN INDUCED ACTIVATION OF THE PLASMA CONTACT SYSTEM. AN IN VITRO STUDY

A. Aasen, B. Bouma, J. Stadaas, 1988, Thrombosis and Haemostasis.

Effect of Heparin on the Activation of Factor XI by Fibrin-bound Thrombin

P. A. von dem Borne, J. Meijers, B. Bouma, 1996, Thrombosis and Haemostasis.

The α-Chains of C4b-binding Protein Mediate Complex Formation with Low Density Lipoprotein Receptor-related Protein*

P. Lenting, C. Denis, E. Westein, 2002, The Journal of Biological Chemistry.

Evaluation of a quality control material containing hemoglobin for blood gas and pH measurement.

W. Zijlstra, B. Bouma, A. Maas, 1987, Scandinavian journal of clinical and laboratory investigation. Supplementum.

Catheter unsuitable for the study of turn-over products of coagulation, fibrinolysis and platelet activation

W. Mosterd, P. Meijer, M. V. Vliet, 1992 .

Quality control material containing hemoglobin for blood gas and pH measurement: improvement of the stability of stroma-free hemoglobin solution.

W. Zijlstra, B. Bouma, A. Maas, 1987, Scandinavian journal of clinical and laboratory investigation. Supplementum.

Expression and Characterization of Recombinant Human Protein S in Heterologous Cells - Studies of the Interaction of Amino Acid Residues Leu-608 to Glu-612 with Human C4b-Binding Protein

P. Reitsma, R. Bertina, H. K. Ploos van Amstel, 1992, Thrombosis and Haemostasis.

The localization of heparin-binding fragments on human C4b-binding protein.

T. Hackeng, B. Bouma, D. Kanters, 1990, Journal of immunology.

The contact activation proteins: a structure/function overview.

J. Meijers, B. Bouma, B. McMullen, 1992, Agents and actions. Supplements.

Analysis of protein S C4b-binding protein interactions by homology modeling and inhibitory antibodies.

J. Griffin, B. Villoutreix, T. Hackeng, 1994, Biochemistry.

The binding site of human C4b-binding protein on complement C4 is localized in the alpha'-chain.

C. van ′t Veer, B. Bouma, M. Hessing, 1990, Journal of immunology.

Predominance of normal low molecular weight forms of factor VIII in "variant" von Willebrand's disease.

J. Sixma, I. Peake, B. Bouma, 1978, Thrombosis research.

Immunological Studies Of Human Factor XI

J. Griffin, B. Bouma, R. Vlooswijk, 1981, Thrombosis and Haemostasis.

A co-operative study for the detection of the carrier state of classic hemophilia.

D. DeMets, H. Klein, L. Aledort, 1977, The New England journal of medicine.

Organization of the human genes for insulin‐like growth factors I and II

F. V. Schaik, J. Sussenbach, B. Bouma, 1986, FEBS letters.

Chorea in systemic lupus erythematosus and "lupus-like" disease: association with antiphospholipid antibodies.

G. Hughes, L. Kater, B. Bouma, 1987, Seminars in arthritis and rheumatism.

Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor.

J. Sixma, C. van ′t Veer, T. Hackeng, 1994, Blood.

Acute inhibitory effect of alcohol on fibrinolysis

A. van de Wiel, R. Kraaijenhagen, B. Bouma, 2001, European journal of clinical investigation.

Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation.

C. Maas, B. Hazenberg, P. D. de Groot, 2008, The Journal of clinical investigation.

Importance of the α3‐fragment of complement C4 for the binding with C4b‐binding protein

S. Iwanaga, T. Hackeng, B. Bouma, 1990 .

Oral contraceptives and the risk of venous thrombosis.

J. Vandenbroucke, F. Rosendaal, S. Middeldorp, 2001, The New England journal of medicine.

Elucidating the structural chemistry of glycosaminoglycan recognition by protein C inhibitor ( molecular modeling / electrostatic complementarity / serpins / heparin / amphipathic ar-helices )

J. Tainer, L. Kuhn, B. Bouma, 2022 .

New Concepts in Activation of the Clotting Cascade in Sepsis

J. Meijers, B. Bouma, 1999 .

Renin-angiotensin system: oral contraception and exercise in healthy female subjects.

W. Erich, M. Schalekamp, B. Bouma, 1985, Journal of applied physiology.

Effect of exercise and oral contraceptive agents on fibrinolytic potential in trained females.

A. Hospers, W. Erich, B. Bouma, 1984, Journal of applied physiology: respiratory, environmental and exercise physiology.

Control of heparin therapy with an activated partial thromboplastin time.

J. Sixma, J. Akkerman, B. Bouma, 1973, The Netherlands journal of medicine.

Immunological characterization of purified anti-haemophilic factor A (factor VIII) which corrects abnormal platelet retention in Von Willebrand's disease.

J. Sixma, J. V. van Mourik, B. Bouma, 1972, Nature: New biology.

The Kallikrein-Kinin System During Bacterial Shock

B. Bouma, E. Kalter, 1981, Thrombosis and Haemostasis.

Contact activation by bacterial fragments

J. Verhoef, B. Bouma, E. Kalter, 1983, Agents and Actions.